By Rick Thompson The Cannabis Benchmarks Weekly Report tells us that a half-dozen companies who market CBD-laden medicines and foods were sent letters this month from the FDA warning them against making claims of health benefits. CBD is the shortened name of cannabidiol, a phytocannabinoid chemical prevalent in cannabis, especially when plants are specifically bred by master growers
To continue reading this story, visit our friend’s website (opens in a new window):: CBD Medicines Face New National Challenges